Active	Status	Sponsor type	Region	Phase	Filter
1 Active 13 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rathmacher, John A
2-HOBA, NCT06432166: 2-Hydroxybenzylamine () Study in Early Alzheimer's Patients	Not yet recruiting	1/2	48	US	2-hydroxybenzylamine acetate, 2-HOBA, Placebo	MTI Biotech Inc, Vanderbilt University Medical Center	Alzheimer Disease, Mild Cognitive Impairment	06/27	12/27